ADAR1 Capital Management »

Avrobio Ord shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Avrobio Ord (AVRO) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Avrobio Ord

Tip: Access up to 7 years of quarterly data

All positions including Avrobio Ord held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avrobio Ord by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $68k 50k 1.36

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Roivant Sciences SHS (ROIV)
Cytokinetics Com New (CYTK)
Arbutus Biopharma (ABUS)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Cerevel Therapeutics Hldng I (CERE)
Mirati Therapeutics
Merck & Co (MRK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Immunovant (IMVT)
Viking Therapeutics (VKTX)
Protagonist Therapeutics (PTGX)

View all positions for ADAR1 Capital Management

Top funds holding Avrobio Ord

Atlas Venture Life Science Advisors
BML Capital Management
Newtyn Management
Vanguard Group
Aisling Capital Management
Ikarian Capital
Vazirani Asset Management
Citadel Advisors
FNY Investment Advisers
Western Standard
Two Sigma Investments
Two Sigma Advisers
Wells Fargo & Company
ADAR1 Capital Management
Barclays

View all funds holding Avrobio Ord